IL-17 inhibitors and ankylosing spondylitis: what to know

Ankylosing spondylitis, also called axial spondyloarthritis, can cause inflammation around the spine and sacroiliac joints. This may appear as persistent back pain, joint stiffness, morning stiffness, or reduced range of motion. IL-17 inhibitors target a messenger involved in inflammation; they do not reverse established structural changes.

A rheumatologist considers symptoms, examination findings, previous treatment, infections, bowel symptoms, eye inflammation, psoriasis, and other health factors before recommending one. The medicine may be given by injection or infusion, depending on the specific product and plan.

Take the medicine exactly as prescribed and keep monitoring appointments so response and side effects can be reviewed. Tell the team about fever, persistent cough, recurrent infections, bowel changes, or a new rash. Ask about vaccines before starting or changing treatment, and do not stop a biologic without discussing the decision.

Medication works best as part of a broader plan. Guided physiotherapy, exercise therapy, and sometimes hydrotherapy can maintain spinal movement, strength, breathing mechanics, and confidence with daily activity. Anti-inflammatory medication may be considered separately when appropriate.

Contact your prescribing team promptly for signs of infection, a severe or spreading rash, persistent diarrhoea, or worsening symptoms after an injection or infusion. Seek urgent help for breathing difficulty, facial swelling, severe weakness, a painful red eye with light sensitivity, or sudden loss of bladder or bowel control.

Ask why an IL-17 inhibitor is suitable, how it will be given, what improvement to track, and when the response will be reviewed. Discuss infection screening, vaccine timing, pregnancy plans, bowel disease, eye symptoms, psoriasis, and which exercises are safe during a flare.